Dr. Ada G Rodriguez-Campuzano holds an undergraduate degree in Chemistry and Biology from the Autonomous University of Guerrero in Mexico. She completed her Master’s and PhD training in the Center for Research and Advanced Studies of the National Polytechnical Institute (Cinvestav) in Mexico City. Her specialization was in neurotoxicology, focusing on understanding the epigenetic mechanisms, translational control and signaling pathways governing the expression of glial glutamatergic transporters in response to various xenobiotics.
Following her PhD, she began a two-year postdoctoral fellowship at the Biomedical Research Institute from the Nacional Autonomous University of Mexico (IIB-UNAM). There, she studied the effects of a non-pathogenic fraction of the tetanus toxin (Tx-Hc), which is endowed with neurotrophic and estrogenic potential, on the expression of cellular amino acid transporters that participate in muscular injury recovery, finding a potential therapeutic approach for Tx-Hc in pelvic floor dysfunctions.
She is currently a postdoctoral fellow at the BRAVE2 lab, where she is elucidating the impact of prenatal opioid exposure (POE) in the developing brain. Her work aims to characterize the epigenetic effects of maladaptive early-life experiences and to evaluate early-life exercise interventions for specifically mitigating the long-lasting negative consequences of POE, particularly those related to deficits in learning and reward-seeking behaviors.